Antitubercular agent-41

CAS No. 901032-23-3

Antitubercular agent-41( —— )

Catalog No. M35315 CAS No. 901032-23-3

Antitubercular agent-41 is a antibacterial agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 153 In Stock
10MG 225 In Stock
25MG 337 In Stock
50MG 465 In Stock
100MG 625 In Stock
200MG 828 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Antitubercular agent-41
  • Note
    Research use only, not for human use.
  • Brief Description
    Antitubercular agent-41 is a antibacterial agent.
  • Description
    Antitubercular agent-41 (Compound 106) is an antitubercular agent that can be used in the study of Mycobacterium tuberculosis infection.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    901032-23-3
  • Formula Weight
    405.42
  • Molecular Formula
    C23H20FN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(C1=CC=2C(=NC=3C(C2)=CC(OC)=CC3)O1)N4CCN(CC4)C5=CC=C(F)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Александр Васильевич Иващенко, et al. FURO- AND THIENO[2,3-b]-QUINOLINE-2-CARBOXAMIDES, METHOD OF PRODUCTION AND ANTITUBERCULOUS ACTIVITY. Patent RU2371444C1.
molnova catalog
related products
  • Cephalotin acid

    Cephalotin acid is a beta-lactam antibiotic inhibits class C β-lactamase AmpC (Ki: 0.32 μM).

  • 4-Aminophenylarsonic...

    4-Aminophenylarsonic acid (Arsanilic Acid) is an organoarsenic compound with activity as an anti-infective agent.

  • N6-(p-Methoxybenzyl)...

    N6-(p-Methoxybenzyl)adenosine is an adenosine analog that shows in vitro antiproliferative activity in U87MG glioma cells and immunogenicity in isolated γδ T cells derived from stimulated peripheral blood mononuclear cells (PBMCs).